{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:43:54Z","timestamp":1794015834137,"version":"4.8.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU113-MF-45"],"award-info":[{"award-number":["CMU113-MF-45"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012544","name":"China Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020950","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2320-B-039-059"],"award-info":[{"award-number":["NSTC 113-2320-B-039-059"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2320-B-039-012"],"award-info":[{"award-number":["113-2320-B-039-012"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.clinme.2025.100336","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T12:26:30Z","timestamp":1748953590000},"page":"100336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparisons of efficacy and safety of immunotherapies for Alzheimer\u2019s disease treatment: A network meta-analysis of randomised controlled trials"],"prefix":"10.1016","volume":"25","author":[{"given":"Ching-Hui","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9913-1041","authenticated-orcid":false,"given":"Ying-Tzu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Shu","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5702-5730","authenticated-orcid":false,"given":"Chan-Yen","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3130-4125","authenticated-orcid":false,"given":"Jin-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9530-192X","authenticated-orcid":false,"given":"Po-Yu","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Jen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1395-4834","authenticated-orcid":false,"given":"Chin-Chuan","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinme.2025.100336_bib0001","unstructured":"Dementia. 2023 15 March 2023 [Accessed 28th April 2024]; Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"issue":"4","key":"10.1016\/j.clinme.2025.100336_bib0002","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer's disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.clinme.2025.100336_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3740461","article-title":"Current Concepts of Neurodegenerative Mechanisms in Alzheimer's Disease","volume":"2018","author":"Magalingam","year":"2018","journal-title":"Biomed Res Int"},{"issue":"10284","key":"10.1016\/j.clinme.2025.100336_bib0004","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.clinme.2025.100336_bib0005","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.neuron.2018.07.039","article-title":"Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease","volume":"99","author":"Eftekharzadeh","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.clinme.2025.100336_bib0006","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer's disease: pathogenesis, diagnostics, and therapeutics","volume":"14","author":"Tiwari","year":"2019","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"10.1016\/j.clinme.2025.100336_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056293","article-title":"Microglia actively regulate the number of functional synapses","volume":"8","author":"Ji","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clinme.2025.100336_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106404","article-title":"Pharmacological targeting of microglia dynamics in Alzheimer's disease: Preclinical and clinical evidence","volume":"184","author":"Yousefizadeh","year":"2022","journal-title":"Pharmacol Res"},{"issue":"26","key":"10.1016\/j.clinme.2025.100336_bib0009","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.2174\/0929867323666161213101126","article-title":"Alzheimer's Disease: A Review from the Pathophysiology to Diagnosis, New Perspectives for Pharmacological Treatment","volume":"25","author":"Dos Santos Picanco","year":"2018","journal-title":"Curr Med Chem"},{"issue":"4","key":"10.1016\/j.clinme.2025.100336_bib0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.37796\/2211-8039.1341","article-title":"The effect of ghrelin on antioxidant status in the rat's model of Alzheimer's disease induced by amyloid-beta","volume":"12","author":"Sarlaki","year":"2022","journal-title":"Biomedicine (Taipei)"},{"key":"10.1016\/j.clinme.2025.100336_bib0011","unstructured":"FDA. FDA Grants Accelerated Approval for Alzheimer\u2019s Drug. 2021 [Accessed 1st, September 2024]; Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-grants-accelerated-approval-alzheimers-drug."},{"key":"10.1016\/j.clinme.2025.100336_bib0012","unstructured":"FDA. FDA Converts Novel Alzheimer\u2019s Disease Treatment to Traditional Approval. 2023 [Accessed 1st, September 2024]; Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-converts-novel-alzheimers-disease-treatment-traditional-approval."},{"key":"10.1016\/j.clinme.2025.100336_bib0013","unstructured":"FDA. FDA approves treatment for adults with Alzheimer\u2019s disease. 2024 [Accessed 1st, September 2024]; Available from: https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-treatment-adults-alzheimers-disease."},{"issue":"1","key":"10.1016\/j.clinme.2025.100336_bib0014","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40035-022-00292-3","article-title":"Immunotherapy for Alzheimer\u2019s disease: targeting \u03b2-amyloid and beyond","volume":"11","author":"Song","year":"2022","journal-title":"Translational Neurodegeneration"},{"issue":"11","key":"10.1016\/j.clinme.2025.100336_bib0015","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinme.2025.100336_bib0016","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.clinme.2025.100336_bib0017","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archneur.65.8.1091","article-title":"Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study","volume":"65","author":"O'Bryant","year":"2008","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.clinme.2025.100336_bib0018","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jalz.2011.01.005","article-title":"Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials","volume":"7","author":"Coley","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"Suppl 2","key":"10.1016\/j.clinme.2025.100336_bib0019","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"10.1016\/j.clinme.2025.100336_bib0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"issue":"11","key":"10.1016\/j.clinme.2025.100336_bib0021","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer's disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.clinme.2025.100336_bib0022","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-170991","article-title":"The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review","volume":"63","author":"Kueper","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.clinme.2025.100336_bib0023","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"issue":"1","key":"10.1016\/j.clinme.2025.100336_bib0024","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Research Synthesis Methods"},{"key":"10.1016\/j.clinme.2025.100336_bib0025","series-title":"Chapter 10: Analysing data and undertaking meta-analyses Cochrane Handbook for Systematic Reviews of Interventions version 6.5","year":"2024"},{"issue":"1","key":"10.1016\/j.clinme.2025.100336_bib0026","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bcp.12150","article-title":"Overview of methods for comparing the efficacies of drugs in the absence of head-to-head clinical trial data","volume":"77","author":"Kim","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"47","key":"10.1016\/j.clinme.2025.100336_bib0027","first-page":"803","article-title":"Indirect Comparisons and Network Meta-Analyses","volume":"112","author":"Kiefer","year":"2015","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"10.1016\/j.clinme.2025.100336_bib0028","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/bimj.201900026","article-title":"Extensions of the probabilistic ranking metrics of competing treatments in network meta-analysis to reflect clinically important relative differences on many outcomes","volume":"62","author":"Mavridis","year":"2020","journal-title":"Biom J"},{"key":"10.1016\/j.clinme.2025.100336_bib0029","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.clinme.2025.100336_bib0030","series-title":"Chapter 6: Choosing effect measures and computing estimates of effect. Cochrane Handbook for Systematic Reviews of Interventions version 6.5","year":"2024"},{"issue":"4","key":"10.1016\/j.clinme.2025.100336_bib0031","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/WNN.0b013e318190cf75","article-title":"Clinical trial design issues in mild to moderate Alzheimer disease","volume":"21","author":"Knopman","year":"2008","journal-title":"Cogn Behav Neurol"},{"key":"10.1016\/j.clinme.2025.100336_bib0032","doi-asserted-by":"crossref","DOI":"10.1177\/1533317520918719","article-title":"Longitudinal Sensitivity of Alzheimer's Disease Severity Staging","volume":"35","author":"Benoit","year":"2020","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"7-8","key":"10.1016\/j.clinme.2025.100336_bib0033","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.clinme.2025.100336_bib0034","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40263-024-01067-2","article-title":"Comparative Efficacy and Safety of Monoclonal Antibodies for Cognitive Decline in Patients with Alzheimer\u2019s Disease: A Systematic Review and Network Meta-Analysis","volume":"38","author":"Qiao","year":"2024","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.clinme.2025.100336_bib0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","article-title":"Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer's Disease","volume":"38","author":"Cummings","year":"2024","journal-title":"BioDrugs"},{"issue":"1","key":"10.1016\/j.clinme.2025.100336_bib0036","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1038\/s41598-018-24501-0","article-title":"Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-\u03b2","volume":"8","author":"Arndt","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.clinme.2025.100336_bib0037","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/brain\/awad005","article-title":"Anti-amyloid antibody therapies in Alzheimer's disease","volume":"146","author":"Perneczky","year":"2023","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.clinme.2025.100336_bib0038","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3174\/ajnr.A3500","article-title":"MR imaging features of amyloid-related imaging abnormalities","volume":"34","author":"Barakos","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"issue":"11","key":"10.1016\/j.clinme.2025.100336_bib0039","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/brain\/awad188","article-title":"Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics","volume":"146","author":"Hampel","year":"2023","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.clinme.2025.100336_bib0040","first-page":"236","article-title":"Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other Tauopathies","volume":"4","author":"West","year":"2017","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.clinme.2025.100336_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105120","article-title":"Characterization of tau binding by gosuranemab","volume":"146","author":"Sopko","year":"2020","journal-title":"Neurobiol Dis"},{"issue":"593","key":"10.1016\/j.clinme.2025.100336_bib0042","doi-asserted-by":"crossref","first-page":"eabb2639","DOI":"10.1126\/scitranslmed.abb2639","article-title":"Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's disease","volume":"13","author":"Ayalon","year":"2021","journal-title":"Sci Transl Med"},{"issue":"7S_Part_11","key":"10.1016\/j.clinme.2025.100336_bib0043","doi-asserted-by":"crossref","first-page":"P592","DOI":"10.1016\/j.jalz.2017.07.227","article-title":"[O2\u201314\u201305]: PRECLINICAL CHARACTERIZATION OF AN ANTIBODY [LY3303560] TARGETING AGGREGATED TAU","volume":"13","author":"Alam","year":"2017","journal-title":"Alzheimer's & Dementia"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211825000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211825000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:49:57Z","timestamp":1778615397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211825000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1470211825000545"],"URL":"https:\/\/doi.org\/10.1016\/j.clinme.2025.100336","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparisons of efficacy and safety of immunotherapies for Alzheimer\u2019s disease treatment: A network meta-analysis of randomised controlled trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinme.2025.100336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of Royal College of Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100336"}}